Quantres Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quantres Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$739K	Buy	1,800 +600	+50%	+$247K	0.54%	57
2018 Q4	$448K	Sell	1,200 -1,000	-45%	-$366K	0.28%	122
2018 Q3	$889K	Sell	2,200 -1,600	-42%	-$609K	0.53%	59
2018 Q2	$1.31M	Buy	3,800 +3,000	+375%	+$938K	0.76%	39
2018 Q1	$275K	Buy	800 +100	+14%	+$34.8K	0.17%	120
2017 Q4	$263K	Sell	700 -2,200	-76%	-$891K	0.17%	172
2017 Q3	$1.3M	Buy	2,900 +1,800	+164%	+$857K	0.83%	33
2017 Q2	$540K	Sell	1,100 -1,600	-59%	-$700K	0.35%	95
2017 Q1	$1.05M	Buy	+2,700	New	+$1M	0.67%	50
2016 Q4	–	Sell	-1,000	Closed	-$402K	–	226
2016 Q3	$402K	Buy	1,000 +400	+67%	+$160K	0.25%	124
2016 Q2	$210K	Buy	+600	New	+$231K	0.13%	160
2015 Q3	–	Sell	-3,700	Closed	-$1.89M	–	180
2015 Q2	$1.89M	Sell	3,700 -200	-5%	-$97.6K	1.49%	14
2015 Q1	$1.76M	Buy	+3,900	New	+$1.65M	1.76%	14
2014 Q3	–	Sell	-2,800	Closed	-$791K	–	207
2014 Q2	$791K	Buy	+2,800	New	+$830K	0.88%	31

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantres Asset Management's REGN Position: Q1 2019 in Review

Quantres Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 50% in Q1 2019, buying an estimated $247K and bringing the position to 1,800 shares worth $739K. The position accounts for 0.54% of the portfolio, ranked #57.

Quantres Asset Management first reported a position in REGN in Q2 2014 and has held it in 14 quarters since. The position peaked at $1.89M in Q2 2015. 719 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

Quantres Asset Management held 1,800 shares of Regeneron Pharmaceuticals worth $739K as of Q1 2019.
Quantres Asset Management bought 600 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $247K.
Regeneron Pharmaceuticals made up 0.54% of Quantres Asset Management's portfolio in Q1 2019, its #57 holding.
Quantres Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 14 quarters since.
Quantres Asset Management's Regeneron Pharmaceuticals position peaked at $1.89M in Q2 2015.
719 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on Quantres Asset Management's 13F filing for Q1 2019, filed 12 Apr 2019.